International Isotopes IncOTCQB:INIS
- LAST PRICE0.0420
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.0380/ 150
- Ask / Lots0.0433/ 100
- Open / Previous Close0.0386 / 0.0420
- Day Range
- 52 Week Range
- Volume16,895
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | INIS |
|---|---|---|
| 09:32 ET | 5895 | 0.041 |
| 11:47 ET | 10000 | 0.043 |
| 03:09 ET | 1000 | 0.042 |
Apr 1, 2024
INTERNATIONAL ISOTOPES INC. ANNOUNCES FISCAL RESULTS FOR FISCAL YEAR 2023, from 9:00AM ET on Monday Apr 01, 2024 by Dow Jones
9:00AM ET on Monday Apr 01, 2024 by Dow JonesPress Release: INTERNATIONAL ISOTOPES INC. ANNOUNCES FISCAL RESULTS FOR FISCAL YEAR 2023, from 9:00AM ET on Monday Apr 01, 2024 by Dow Jones
9:00AM ET on Monday Apr 01, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
International Isotopes Inc | 21.8M | -25.0x | --- |
Intelligent Living Application Group Inc | 9.8M | -2.5x | --- |
Autoscope Technologies Corp | 35.0M | 8.9x | -26.17% |
Mingteng International Corp Inc | 24.2M | 14.3x | --- |
Electro-Sensors Inc | 14.2M | 50.2x | --- |
Lifeloc Technologies Inc | 8.2M | 40.6x | -0.62% |
Company Information
International Isotopes Inc. manufactures a range of nuclear medicine calibration and reference standards. Its Theranostics Products Segment includes production and distribution of Iodine-131 generic drug products and various isotopically pure radiochemicals. Its Cobalt Products segment includes management of a cobalt irradiation contract, fabrication of cobalt capsules for teletherapy or irradiation devices, and recycling of expended cobalt sources. Its Nuclear Medicine Standards segment consists of the manufacture of sources and standards associated with Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET) imaging, patient positioning, and calibration or operational testing of dose measuring equipment for the nuclear pharmacy industry. Its Fluorine Products segment is involved in the production of small-scale qualification samples of purity fluoride gas for various industrial applications, and development of laboratory and analytical processes.
Contact Information
- Headquarters
- 4137 Commerce CirIDAHO FALLS, ID, United States 83401-1205
- Phone
- 208-524-5300
- Fax
- 208-524-1411
Executives
- Non-Executive Independent Chairman of the Board
- Christopher Grosso
- President
- Shahe Bagerdjian
- Chief Financial Officer, Secretary
- Matthew Cox
- Director
- Steve Laflin
- Independent Director
- Robert Atcher
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $21.8M |
|---|---|
Revenue (TTM) | $12.3M |
Shares Outstanding | 520.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.57 |
EPS | $0.00 |
Book Value | $0.01 |
P/E Ratio | -25.0x |
Price/Sales (TTM) | 1.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -6.33% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
